Business Description
IQVIA Holdings Inc
NAICS : 621399
SIC : 8099
4820 Emperor Boulevard, Durham, NC, USA, 27703
Compare
Compare
Traded in other countries / regions
IQVH.Austria
•
I1QV34.Brazil
•
QTS.Germany
•
IQV.Mexico
•
0JDM.UK
•
IQV.USA
Description
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | 0.22 | |||||
| Debt-to-Equity | 2.44 | |||||
| Debt-to-EBITDA | 4.56 | |||||
| Interest Coverage | 4.78 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.41 | |||||
| Beneish M-Score | -2.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.5 | |||||
| 3-Year EBITDA Growth Rate | 16.2 | |||||
| 3-Year EPS without NRI Growth Rate | 58.6 | |||||
| 3-Year FCF Growth Rate | 45.7 | |||||
| 3-Year Book Growth Rate | -2.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | 15.51 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 8.06 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 83.61 | |||||
| 9-Day RSI | 75.56 | |||||
| 14-Day RSI | 70.33 | |||||
| 6-1 Month Momentum % | -12.59 | |||||
| 12-1 Month Momentum % | -13.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.96 | |||||
| Quick Ratio | 0.96 | |||||
| Cash Ratio | 0.3 | |||||
| Days Sales Outstanding | 31.24 | |||||
| Days Payable | 92.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 1.2 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 34.42 | |||||
| Operating Margin % | 12.25 | |||||
| Net Margin % | 8.21 | |||||
| ROE % | 20.07 | |||||
| ROA % | 4.75 | |||||
| ROIC % | 6.68 | |||||
| ROC (Joel Greenblatt) % | 191.98 | |||||
| ROCE % | 8.98 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 41.04 | |||||
| Forward PE Ratio | 24.21 | |||||
| PE Ratio without NRI | 41.04 | |||||
| Shiller PE Ratio | 76.78 | |||||
| Price-to-Owner-Earnings | 28.86 | |||||
| PEG Ratio | 2.25 | |||||
| PS Ratio | 3.37 | |||||
| PB Ratio | 8.57 | |||||
| Price-to-Free-Cash-Flow | 28.3 | |||||
| Price-to-Operating-Cash-Flow | 20.12 | |||||
| EV-to-EBIT | 33 | |||||
| EV-to-Forward-EBIT | 24.01 | |||||
| EV-to-EBITDA | 20.05 | |||||
| EV-to-Forward-EBITDA | 18.04 | |||||
| EV-to-Revenue | 4.06 | |||||
| EV-to-Forward-Revenue | 3.96 | |||||
| EV-to-FCF | 33.97 | |||||
| Price-to-Projected-FCF | 2.25 | |||||
| Price-to-DCF (Earnings Based) | 3.03 | |||||
| Price-to-DCF (FCF Based) | 0.74 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.45 | |||||
| Earnings Yield (Greenblatt) % | 3.03 | |||||
| Forward Rate of Return (Yacktman) % | 19.28 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NYSE:IQV
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 14,136 | ||
| EPS (TTM) ($) | 5.99 | ||
| Beta | 1.42 | ||
| Volatility % | 25.75 | ||
| 14-Day RSI | 70.33 | ||
| 14-Day ATR ($) | 6.114676 | ||
| 20-Day SMA ($) | 230.594 | ||
| 12-1 Month Momentum % | -13.29 | ||
| 52-Week Range ($) | 194.67 - 285.61 | ||
| Shares Outstanding (Mil) | 186.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IQVIA Holdings Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||